The United States will begin participating in an international collaboration to distribute COVID-19 vaccines more equitably around the world after President Joe Biden reversed the Trump administration’s withdrawal from the World Health Organization on his first day in office. Richard Marlink, the director of Rutgers Global Health Institute, discusses the impact COVAX, the global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, will have on ending the COVID-19 pandemic and strengthening global health. To read the full story.
Recent Posts
- Rutgers-Newark Searches for New Ways to Enroll Men in Alzheimer’s Studies.
- Clinical Trials Day 2026 is May 20th – Submit an Abstract by February 13th
- Clinical trial in N.J. gives patients with incurable cancer a new chance at life.
- Entrepreneurship Lessons Coming to Introductory Engineering Courses.
- Scientists Develop Plastics That Can Break Down, Tackling Pollution.
Categories
- Community (2,431)
- Covid (996)
- CTO Events (6)
- News (3,078)
- Pilots (21)